AKT2 and cancer: Fifteen (11.9%) cancers harbored 16 PI3K pathway mutations: PIK3CA (n = 7), AKT2 and RICTOR (n = 3 each), PTEN, PIK3C2B, and PIK3R1 (n = 1 each).